Literature DB >> 14711057

HLA-G molecules: from maternal-fetal tolerance to tissue acceptance.

Edgardo D Carosella1, Philippe Moreau, Joël Le Maoult, Magali Le Discorde, Jean Dausset, Nathalie Rouas-Freiss.   

Abstract

Over the past few years, HLA-G, the non-classical HLA class I molecule, has been the center of investigations that have led to the description of its specific structural and functional properties. Although located in the HLA class I region of chromosome six, the HLA-G gene may be distinguished from other HLA class I genes by its low polymorphism and alternative splicing that generates seven HLA-G proteins, whose tissue-distribution is restricted to normal fetal and adult tissues that display a tolerogeneic function toward both innate and acquired immune cells. We review these points, with special emphasis on the role of HLA-G in human pathologies, such as cancer, viral infection, and inflammatory diseases, as well as in organ transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14711057     DOI: 10.1016/s0065-2776(03)81006-4

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  73 in total

1.  Tumor-derived HLA-G1 acquisition by monocytes through trogocytosis: possible functional consequences.

Authors:  Channakeshava Sokke Umeshappa; Jim Xiang
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

Review 2.  Janus head: the dual role of HLA-G in CNS immunity.

Authors:  Yu-Hwa Huang; Laura Airas; Nicholas Schwab; Heinz Wiendl
Journal:  Cell Mol Life Sci       Date:  2010-11-18       Impact factor: 9.261

3.  On the definition of a criterion of immunogenicity.

Authors:  Thomas Pradeu; Edgardo D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

4.  HLA-G is found in lipid rafts and can act as a signaling molecule.

Authors:  Martina Comiskey; Kenneth E Domino; Carol M Warner
Journal:  Hum Immunol       Date:  2006-11-03       Impact factor: 2.850

5.  sHLA-G involved in the apoptosis of decidual natural killer cells following Toxoplasma gondii infection.

Authors:  Meiyu Han; Yuzhu Jiang; Kaixue Lao; Xiaoyan Xu; Shaowei Zhan; Yanlin Wang; Xuemei Hu
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

6.  Modulation of HLA-G expression in human neural cells after neurotropic viral infections.

Authors:  Monique Lafon; Christophe Prehaud; Françoise Megret; Mireille Lafage; Gaël Mouillot; Michèle Roa; Philippe Moreau; Nathalie Rouas-Freiss; Edgardo D Carosella
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 7.  The HLA-G 14-bp polymorphism and recurrent implantation failure: a meta-analysis.

Authors:  Wei Fan; Zhongying Huang; Shangwei Li; Zhun Xiao
Journal:  J Assist Reprod Genet       Date:  2017-07-13       Impact factor: 3.412

Review 8.  Rationale for the potential use of mesenchymal stromal cells in liver transplantation.

Authors:  Morgan Vandermeulen; Céline Grégoire; Alexandra Briquet; Chantal Lechanteur; Yves Beguin; Olivier Detry
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 9.  Are stem cells a potential therapeutic tool in coeliac disease?

Authors:  Rachele Ciccocioppo; Giuseppina Cristina Cangemi; Emanuela Anna Roselli; Peter Kruzliak
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

10.  Low expression of human histocompatibility soluble leukocyte antigen-G (HLA-G5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV).

Authors:  Marcia C M Guimarães; Christiane P Soares; Eduardo A Donadi; Sophie F M Derchain; Liliana A L A Andrade; Tarsia G A Silva; Marcela K Hassumi; Renata T Simões; Fabiana A Miranda; Régia C P Lira; Janaina Crispim; Edson G Soares
Journal:  J Histochem Cytochem       Date:  2009-09-28       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.